TPIDB > Principal Investigator
Principal Investigator
National Taiwan University Hospital
(在職)
Division of Obstetrics & Gynecology
Division of General Internal Medicine
Division of Hematology & Oncology
更新時間：2023-09-19
鄭文芳Cheng, Wen-Fang
- Principal Investigator
- Clinical Trial Experience (year) 17 years 9 個月
Publication
21Publications
11
Chen YL, Lin HW, Chien CL, Lai YL, Sun WZ, Chen CA, Cheng WF. BTLA blockade enhances Cancer therapy by inhibiting IL-6/IL-10-induced CD19high B lymphocytes. J Immunother Cancer. 2019 Nov 21;7(1):313. doi: 10.1186/s40425-019-0744-4. PMID: 31753019; PMCID: PMC6868712.
12
Lu TP, Kuo KT, Chen CH, Chang MC, Lin HP, Hu YH, Chiang YC, Cheng WF, Chen CA. Developing a Prognostic Gene Panel of Epithelial Ovarian Cancer Patients by a Machine Learning Model. Cancers (Basel). 2019 Feb 25;11(2):270. doi: 10.3390/cancers11020270. PMID: 30823599; PMCID: PMC6406249.
13
Sun NY, Chen YL, Lin HW, Chiang YC, Chang CF, Tai YJ, Chen CA, Sun WZ, Chien CL, Cheng WF. Immune checkpoint Ab enhances the antigen-specific anti-tumor effects by modulating both dendritic cells and regulatory T lymphocytes. Cancer Lett. 2019 Mar 1;444:20-34. doi: 10.1016/j.canlet.2018.11.039. Epub 2018 Dec 10. PMID: 30543813.
14
Hsieh SF, Lau HY, Wu HH, Hsu HC, Twu NF, Cheng WF. Prognostic Factors of Early Stage Epithelial Ovarian Carcinoma. Int J Environ Res Public Health. 2019 Feb 21;16(4):637. doi: 10.3390/ijerph16040637. PMID: 30795566; PMCID: PMC6406698.
15
Chen YL, Lin HW, Sun NY, Yie JC, Hung HC, Chen CA, Sun WZ, Cheng WF. mTOR Inhibitors Can Enhance the Anti-Tumor Effects of DNA Vaccines through Modulating Dendritic Cell Function in the Tumor Microenvironment. Cancers (Basel). 2019 May 2;11(5):617. doi: 10.3390/cancers11050617. PMID: 31052575; PMCID: PMC6562783.
16
Tai YJ, Hsu HC, Chiang YC, Chen YL, Chen CA, Cheng WF. Impact of Adjuvant Modalities on Survival in Patients with Advanced Stage Endometrial Carcinoma: A Retrospective Analysis from a Tertiary Medical Center. Int J Environ Res Public Health. 2019 Jul 18;16(14):2561. doi: 10.3390/ijerph16142561. PMID: 31323767; PMCID: PMC6678420.
17
Lee SP, Hsu HC, Tai YJ, Chen YL, Chiang YC, Chen CA, Cheng WF. Bevacizumab Dose Affects the Severity of Adverse Events in Gynecologic Malignancies. Front Pharmacol. 2019 Apr 26;10:426. doi: 10.3389/fphar.2019.00426. PMID: 31105567; PMCID: PMC6498445.
18
Tang CH, Cheng WF, Jiang JH, You SL, Huang LW, Hsieh JY, Mukherjee P, Van Kriekinge G, Lee C. Cost-Effectiveness Analysis of Human Papillomavirus Vaccination in Adolescent Girls in Taiwan. Asian Pac J Cancer Prev. 2019 May 25;20(5):1377-1387. doi: 10.31557/APJCP.2019.20.5.1377. PMID: 31127896; PMCID: PMC6857899.
19
Lin HW, Chiang YC, Sun NY, Chen YL, Chang CF, Tai YJ, Chen CA, Cheng WF. CHI3L1 results in poor outcome of ovarian cancer by promoting properties of stem-like cells. Endocr Relat Cancer. 2019 Jan 1;26(1):73-88. doi: 10.1530/ERC-18-0300. PMID: 30121622.
20
Lai YL, Hsu HC, Kuo KT, Chen YL, Chen CA, Cheng WF. Clear Cell Carcinoma of the Abdominal Wall as a Rare Complication of General Obstetric and Gynecologic Surgeries: 15 Years of Experience at a Large Academic Institution. Int J Environ Res Public Health. 2019 Feb 14;16(4):552. doi: 10.3390/ijerph16040552. PMID: 30769847; PMCID: PMC6406533.
